Related Experiment Video
Updated: May 12, 2026

12:45
Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
Left Bundle Branch Area Pacing vs. Biventricular Pacing for Cardiac Resynchronization: Propensity Score Analysis
Fawzi Kerkouri1,2, Pierre Khattar3, Vincent Mansourati1
1Department of Cardiology University Hospital of Brest Brest France.
Journal of Arrhythmia
|May 11, 2026
Summary
Left bundle branch area pacing (LBBAP) offers comparable cardiac resynchronization therapy outcomes to biventricular pacing (BIVP) but with fewer complications. This study shows LBBAP is a safe and effective alternative for CRT.
Area of Science:
- Cardiology
- Electrophysiology
- Medical Devices
Background:
- Left bundle branch area pacing (LBBAP) is an emerging alternative to biventricular pacing (BIVP) for cardiac resynchronization therapy (CRT).
- Previous data suggest LBBAP may offer superior outcomes, but more evidence is needed.
- This study compares LBBAP and BIVP for de novo CRT indications.
Purpose of the Study:
- To compare procedural and clinical outcomes between LBBAP and BIVP in patients undergoing de novo cardiac resynchronization therapy.
- To evaluate the safety and efficacy of LBBAP as an alternative to BIVP.
- To assess long-term outcomes including heart failure hospitalizations and mortality.
Main Methods:
- Retrospective study of 314 patients undergoing de novo CRT at two French centers (2022-2024).
- Patients were divided into LBBAP (n=75) and BIVP (n=239) groups.
- Inverse probability weighting propensity score (IPW-PS) was used to compare outcomes.
Main Results:
- LBBAP was associated with shorter procedure times, narrower paced QRS, and fewer post-discharge complications compared to BIVP.
- One-year improvements in left ventricular ejection fraction and hyper-response rates were similar between groups.
- After IPW-PS, no significant differences were found in heart failure hospitalizations, arrhythmias, or mortality between LBBAP and BIVP.
Conclusions:
- LBBAP demonstrates comparable resynchronization and clinical outcomes to BIVP for cardiac resynchronization therapy.
- LBBAP is associated with a significant reduction in late device-related complications.
- LBBAP represents a viable and potentially safer alternative to conventional BIVP.

